Medicines for Europe

📍 Brussels, Belgium🗓 Founded 1993👥 61 employees💰 Last funded Jan 2026
Pharmaceutical Manufacturing🌐 medicinesforeurope.com
Website LinkedIn
Medicines for Europe represents the generic, biosimilar and value-added medicines industries across Europe. Its vision is to provide sustainable access to high quality medicines, based on 5 important pillars: patients, quality, value, sustainability and partnership. Its members directly employ 190,000 people at over 400 manufacturing and 126 R&D sites in Europe and invest up to 17% of their turnover in R&D investment. Medicines for Europe member companies across Europe are both increasing access to medicines and driving improved health outcomes. They play a key role in creating sustainable European healthcare systems by continuing to provide high quality, effective generic medicines, whilst also innovating to create new biosimilar medicines and bringing to market value added medicines, which deliver better health outcomes, greater efficiency and/or improved safety in the hospital setting for patients.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1993
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Medicines for Europe?
Medicines for Europe has 1 investors on record on gritt.io.
When did Medicines for Europe last raise funding?
The most recent investment in Medicines for Europe recorded on gritt.io was in January 2026.
When was Medicines for Europe founded?
Medicines for Europe was founded in 1993.
What industry is Medicines for Europe in?
Medicines for Europe operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Medicines for Europe based?
Medicines for Europe is headquartered in Brussels, Belgium.